The use of urecholine in the prevention of postpartum urinary retention; final report.
D001626:Bethanechol Compounds; D035843:Biomedical Research; D005260:Female; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use*; D049590:Postpartum Period / Q000150:complications*; D011247:Pregnancy; D016055:Urinary Retention; D014555:Urination Disorders
D001626:Bethanechol Compounds; D010277:Parasympathomimetics
PARASYMPATHOMIMETICS/therapeutic use; PUERPERIUM/complications; URINATION DISORDERS/in pregnancy